Highlights

[PHARMA] YoY Quarter Result on 2010-12-31 [#4]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 25-Feb-2011
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2010
Quarter 31-Dec-2010  [#4]
Profit Trend QoQ -     -126.28%    YoY -     -110.29%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Revenue 567,860 482,404 367,786 376,116 323,906 328,243 292,817 11.66%
  YoY % 17.71% 31.16% -2.21% 16.12% -1.32% 12.10% -
  Horiz. % 193.93% 164.75% 125.60% 128.45% 110.62% 112.10% 100.00%
PBT 33,007 4,248 16,368 -2,701 27,490 24,496 23,572 5.77%
  YoY % 677.00% -74.05% 706.00% -109.83% 12.22% 3.92% -
  Horiz. % 140.03% 18.02% 69.44% -11.46% 116.62% 103.92% 100.00%
Tax -11,740 -11,716 -4,186 749 -5,372 -6,574 -7,125 8.67%
  YoY % -0.20% -179.89% -658.88% 113.94% 18.28% 7.73% -
  Horiz. % 164.77% 164.44% 58.75% -10.51% 75.40% 92.27% 100.00%
NP 21,267 -7,468 12,182 -1,952 22,118 17,922 16,447 4.37%
  YoY % 384.78% -161.30% 724.08% -108.83% 23.41% 8.97% -
  Horiz. % 129.31% -45.41% 74.07% -11.87% 134.48% 108.97% 100.00%
NP to SH 20,813 -7,934 11,942 -2,256 21,914 17,789 16,069 4.40%
  YoY % 362.33% -166.44% 629.34% -110.29% 23.19% 10.70% -
  Horiz. % 129.52% -49.37% 74.32% -14.04% 136.37% 110.70% 100.00%
Tax Rate 35.57 % 275.80 % 25.57 % - % 19.54 % 26.84 % 30.23 % 2.75%
  YoY % -87.10% 978.61% 0.00% 0.00% -27.20% -11.21% -
  Horiz. % 117.66% 912.34% 84.58% 0.00% 64.64% 88.79% 100.00%
Total Cost 546,593 489,872 355,604 378,068 301,788 310,321 276,370 12.03%
  YoY % 11.58% 37.76% -5.94% 25.28% -2.75% 12.28% -
  Horiz. % 197.78% 177.25% 128.67% 136.80% 109.20% 112.28% 100.00%
Net Worth 486,672 472,037 514,153 421,262 431,217 388,298 349,837 5.65%
  YoY % 3.10% -8.19% 22.05% -2.31% 11.05% 10.99% -
  Horiz. % 139.11% 134.93% 146.97% 120.42% 123.26% 110.99% 100.00%
Dividend
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Div 16,049 11,771 35,296 - 39,590 28,881 19,257 -2.99%
  YoY % 36.34% -66.65% 0.00% 0.00% 37.08% 49.98% -
  Horiz. % 83.34% 61.13% 183.29% 0.00% 205.59% 149.98% 100.00%
Div Payout % 77.11 % - % 295.57 % - % 180.66 % 162.36 % 119.84 % -7.08%
  YoY % 0.00% 0.00% 0.00% 0.00% 11.27% 35.48% -
  Horiz. % 64.34% 0.00% 246.64% 0.00% 150.75% 135.48% 100.00%
Equity
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Net Worth 486,672 472,037 514,153 421,262 431,217 388,298 349,837 5.65%
  YoY % 3.10% -8.19% 22.05% -2.31% 11.05% 10.99% -
  Horiz. % 139.11% 134.93% 146.97% 120.42% 123.26% 110.99% 100.00%
NOSH 258,868 117,715 117,655 106,919 107,001 106,969 106,984 15.85%
  YoY % 119.91% 0.05% 10.04% -0.08% 0.03% -0.01% -
  Horiz. % 241.97% 110.03% 109.97% 99.94% 100.02% 99.99% 100.00%
Ratio Analysis
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
NP Margin 3.75 % -1.55 % 3.31 % -0.52 % 6.83 % 5.46 % 5.62 % -6.51%
  YoY % 341.94% -146.83% 736.54% -107.61% 25.09% -2.85% -
  Horiz. % 66.73% -27.58% 58.90% -9.25% 121.53% 97.15% 100.00%
ROE 4.28 % -1.68 % 2.32 % -0.54 % 5.08 % 4.58 % 4.59 % -1.16%
  YoY % 354.76% -172.41% 529.63% -110.63% 10.92% -0.22% -
  Horiz. % 93.25% -36.60% 50.54% -11.76% 110.68% 99.78% 100.00%
Per Share
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
RPS 219.36 409.81 312.60 351.78 302.71 306.86 273.70 -3.62%
  YoY % -46.47% 31.10% -11.14% 16.21% -1.35% 12.12% -
  Horiz. % 80.15% 149.73% 114.21% 128.53% 110.60% 112.12% 100.00%
EPS 8.04 -6.74 10.15 -2.11 20.48 16.63 15.02 -9.88%
  YoY % 219.29% -166.40% 581.04% -110.30% 23.15% 10.72% -
  Horiz. % 53.53% -44.87% 67.58% -14.05% 136.35% 110.72% 100.00%
DPS 6.20 10.00 30.00 0.00 37.00 27.00 18.00 -16.26%
  YoY % -38.00% -66.67% 0.00% 0.00% 37.04% 50.00% -
  Horiz. % 34.44% 55.56% 166.67% 0.00% 205.56% 150.00% 100.00%
NAPS 1.8800 4.0100 4.3700 3.9400 4.0300 3.6300 3.2700 -8.80%
  YoY % -53.12% -8.24% 10.91% -2.23% 11.02% 11.01% -
  Horiz. % 57.49% 122.63% 133.64% 120.49% 123.24% 111.01% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
RPS 217.38 184.67 140.79 143.98 123.99 125.65 112.09 11.66%
  YoY % 17.71% 31.17% -2.22% 16.12% -1.32% 12.10% -
  Horiz. % 193.93% 164.75% 125.60% 128.45% 110.62% 112.10% 100.00%
EPS 7.97 -3.04 4.57 -0.86 8.39 6.81 6.15 4.41%
  YoY % 362.17% -166.52% 631.40% -110.25% 23.20% 10.73% -
  Horiz. % 129.59% -49.43% 74.31% -13.98% 136.42% 110.73% 100.00%
DPS 6.14 4.51 13.51 0.00 15.16 11.06 7.37 -2.99%
  YoY % 36.14% -66.62% 0.00% 0.00% 37.07% 50.07% -
  Horiz. % 83.31% 61.19% 183.31% 0.00% 205.70% 150.07% 100.00%
NAPS 1.8630 1.8070 1.9682 1.6126 1.6507 1.4864 1.3392 5.65%
  YoY % 3.10% -8.19% 22.05% -2.31% 11.05% 10.99% -
  Horiz. % 139.11% 134.93% 146.97% 120.42% 123.26% 110.99% 100.00%
Price Multiplier on Financial Quarter End Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Date 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 31/12/08 31/12/07 -
Price 4.4500 8.1000 5.3600 5.3100 4.0000 3.3600 2.9300 -
P/RPS 2.03 1.98 1.71 1.51 1.32 1.09 1.07 11.25%
  YoY % 2.53% 15.79% 13.25% 14.39% 21.10% 1.87% -
  Horiz. % 189.72% 185.05% 159.81% 141.12% 123.36% 101.87% 100.00%
P/EPS 55.35 -120.18 52.81 -251.66 19.53 20.20 19.51 18.96%
  YoY % 146.06% -327.57% 120.98% -1,388.58% -3.32% 3.54% -
  Horiz. % 283.70% -615.99% 270.68% -1,289.90% 100.10% 103.54% 100.00%
EY 1.81 -0.83 1.89 -0.40 5.12 4.95 5.13 -15.93%
  YoY % 318.07% -143.92% 572.50% -107.81% 3.43% -3.51% -
  Horiz. % 35.28% -16.18% 36.84% -7.80% 99.81% 96.49% 100.00%
DY 1.39 1.23 5.60 0.00 9.25 8.04 6.14 -21.91%
  YoY % 13.01% -78.04% 0.00% 0.00% 15.05% 30.94% -
  Horiz. % 22.64% 20.03% 91.21% 0.00% 150.65% 130.94% 100.00%
P/NAPS 2.37 2.02 1.23 1.35 0.99 0.93 0.90 17.50%
  YoY % 17.33% 64.23% -8.89% 36.36% 6.45% 3.33% -
  Horiz. % 263.33% 224.44% 136.67% 150.00% 110.00% 103.33% 100.00%
Price Multiplier on Announcement Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Date 24/02/14 18/02/13 22/02/12 25/02/11 19/02/10 27/02/09 28/02/08 -
Price 4.2900 7.8000 5.9000 5.3500 4.0500 2.7300 2.9800 -
P/RPS 1.96 1.90 1.89 1.52 1.34 0.89 1.09 10.26%
  YoY % 3.16% 0.53% 24.34% 13.43% 50.56% -18.35% -
  Horiz. % 179.82% 174.31% 173.39% 139.45% 122.94% 81.65% 100.00%
P/EPS 53.36 -115.73 58.13 -253.55 19.78 16.42 19.84 17.91%
  YoY % 146.11% -299.09% 122.93% -1,381.85% 20.46% -17.24% -
  Horiz. % 268.95% -583.32% 292.99% -1,277.97% 99.70% 82.76% 100.00%
EY 1.87 -0.86 1.72 -0.39 5.06 6.09 5.04 -15.22%
  YoY % 317.44% -150.00% 541.03% -107.71% -16.91% 20.83% -
  Horiz. % 37.10% -17.06% 34.13% -7.74% 100.40% 120.83% 100.00%
DY 1.45 1.28 5.08 0.00 9.14 9.89 6.04 -21.15%
  YoY % 13.28% -74.80% 0.00% 0.00% -7.58% 63.74% -
  Horiz. % 24.01% 21.19% 84.11% 0.00% 151.32% 163.74% 100.00%
P/NAPS 2.28 1.95 1.35 1.36 1.00 0.75 0.91 16.53%
  YoY % 16.92% 44.44% -0.74% 36.00% 33.33% -17.58% -
  Horiz. % 250.55% 214.29% 148.35% 149.45% 109.89% 82.42% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

292  614  559  986 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 LCTITAN 2.13-0.27 
 SUPERMX-C1I 0.145-0.005 
 LUSTER 0.165-0.005 
 MAHSING 0.96-0.04 
 HWGB 0.78+0.065 
 DATAPRP 0.195-0.025 
 DGSB 0.225+0.01 
 KSTAR 0.43+0.06 
 MTOUCHE 0.045-0.01 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
6. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
7. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
8. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
PARTNERS & BROKERS